Exclusive

Publication

Byline

Clinical Trial: THE EFFECT OF BITTER ORANGE (CITRUS AURANTIUM) OIL AROMATHERAPY ON SLEEP QUALITY AND FATIGUE LEVELS

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756151) titled 'THE EFFECT OF BITTER ORANGE (CITRUS AURANTIUM) OIL AROMATHERAPY ON SLEEP QUALITY AND FATIGU... Read More


Clinical Trial: Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756593) titled 'Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Re... Read More


Clinical Trial: Effects of an Eight-Week Small-Sided Games Training Program on Aerobic Endurance and Passing Performance in Adolescent Soccer Players

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755358) titled 'Effects of an Eight-Week Small-Sided Games Training Program on Aerobic Endurance and Passin... Read More


Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More


Clinical Trial: Weighted vs Unweighted Plyometric Conditioning on Vertical Jump Performance in Young Male Soccer Players

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755345) titled 'Weighted vs Unweighted Plyometric Conditioning on Vertical Jump Performance in Young Male S... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More


Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More


Clinical Trial: Precure Targeted Accrual and Rapid Growth in Enrollment Trial Study

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756320) titled 'Precure Targeted Accrual and Rapid Growth in Enrollment Trial Study' on July 28. Brief Sum... Read More


Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More